Article info
PDFImages in…
Miller Fisher syndrome after Pfizer BioNTech vaccine booster responsive to intravenous Ig treatment
- Correspondence to Dr Baibing Chen; baibingchen.yale{at}gmail.com
Citation
Miller Fisher syndrome after Pfizer BioNTech vaccine booster responsive to intravenous Ig treatment
Publication history
- Accepted October 28, 2022
- First published November 10, 2022.
Online issue publication
January 24, 2024
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© BMJ Publishing Group Limited 2022. No commercial re-use. See rights and permissions. Published by BMJ. This article is made freely available for personal use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.https://bmj.com/coronavirus/usage